Biopol Chemicals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Cash & Equivalents	11.48	0.82
Cash & Short-Term Investments	11.48	0.82
Cash Growth	1295.26%	-
Accounts Receivable	166.56	101.31
Other Receivables	8.16	7.1
Receivables	174.72	108.41
Inventory	118.14	61.33
Prepaid Expenses	0.5	-
Other Current Assets	7.17	1.99
Total Current Assets	312.02	172.55
Property, Plant & Equipment	2.23	2.71
Other Intangible Assets	0.02	0.01
Long-Term Deferred Tax Assets	0.37	0.29
Other Long-Term Assets	0.12	0.01
Total Assets	314.75	175.57
Accounts Payable	85.35	38.38
Accrued Expenses	2.67	2.57
Short-Term Debt	68.13	35.77
Current Portion of Long-Term Debt	2.43	-
Current Income Taxes Payable	12.97	2.98
Other Current Liabilities	1	3.4
Total Current Liabilities	172.55	83.09
Long-Term Debt	6.3	-
Pension & Post-Retirement Benefits	0.59	0.46
Total Liabilities	179.44	83.56
Common Stock	79.11	79.11
Additional Paid-In Capital	0.89	0.89
Retained Earnings	55.31	12.01
Shareholders' Equity	135.31	92.01
Total Liabilities & Equity	314.75	175.57
Total Debt	76.85	35.77
Net Cash (Debt)	-65.37	-34.94
Net Cash Per Share	-8.26	-
Filing Date Shares Outstanding	10.81	-
Total Common Shares Outstanding	7.91	-
Working Capital	139.47	89.46
Book Value Per Share	17.10	-
Tangible Book Value	135.29	92
Tangible Book Value Per Share	17.10	-
Machinery	4.47	3.65
Construction In Progress	-	0.59

Source: S&P Capital IQ. Standard template. Financial Sources.